Skip to main content

Measuring Quality of Life in Persons With Dementia

  • Peter V. Rabins (a1)

The development of treatment outcome measures has followed a pattern in which treatments are first developed to affect symptoms, and measures are developed concomitantly to detect differences in response rates between the treatment group and a comparison placebo group. For example, in the 1950s, distinct pharmacologic therapies were developed to lower blood pressure and to lessen the hallucinations and delusions associated with schizophrenia. At the same time, measures to assess these latter outcomes were validated.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 18 *
Loading metrics...

Abstract views

Total abstract views: 128 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd March 2018. This data will be updated every 24 hours.